FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:MTOR-GARNL3 (FusionGDB2 ID:55516)

Fusion Gene Summary for MTOR-GARNL3

check button Fusion gene summary
Fusion gene informationFusion gene name: MTOR-GARNL3
Fusion gene ID: 55516
HgeneTgene
Gene symbol

MTOR

GARNL3

Gene ID

2475

84253

Gene namemechanistic target of rapamycin kinaseGTPase activating Rap/RanGAP domain like 3
SynonymsFRAP|FRAP1|FRAP2|RAFT1|RAPT1|SKSbA356B19.1
Cytomap

1p36.22

9q33.3

Type of geneprotein-codingprotein-coding
Descriptionserine/threonine-protein kinase mTORFK506 binding protein 12-rapamycin associated protein 2FK506-binding protein 12-rapamycin complex-associated protein 1FKBP-rapamycin associated proteinFKBP12-rapamycin complex-associated protein 1mammalian target oGTPase-activating Rap/Ran-GAP domain-like protein 3GTPase activating RANGAP domain-like 3
Modification date2020032920200313
UniProtAcc

P42345

Q5VVW2

Ensembl transtripts involved in fusion geneENST00000361445, ENST00000376838, 
ENST00000495435, 		ENST00000435213, 
ENST00000314904, ENST00000373387, 
ENST00000496711, 
Fusion gene scores* DoF score11 X 13 X 7=10018 X 10 X 8=640
# samples 1311
** MAII scorelog2(13/1001*10)=-2.94485844580754
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(11/640*10)=-2.5405683813627
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: MTOR [Title/Abstract] AND GARNL3 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointMTOR(11217209)-GARNL3(130151183), # samples:3
Anticipated loss of major functional domain due to fusion event.MTOR-GARNL3 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF.
MTOR-GARNL3 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
MTOR-GARNL3 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
MTOR-GARNL3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
MTOR-GARNL3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneMTOR

GO:0001558

regulation of cell growth

18762023

HgeneMTOR

GO:0001934

positive regulation of protein phosphorylation

20233713

HgeneMTOR

GO:0006468

protein phosphorylation

12150926|15467718|18925875

HgeneMTOR

GO:0009267

cellular response to starvation

28223137

HgeneMTOR

GO:0010507

negative regulation of autophagy

30704899

HgeneMTOR

GO:0016242

negative regulation of macroautophagy

25327288

HgeneMTOR

GO:0016310

phosphorylation

11853878|25327288

HgeneMTOR

GO:0031667

response to nutrient levels

29750193

HgeneMTOR

GO:0034198

cellular response to amino acid starvation

22424946

HgeneMTOR

GO:0038202

TORC1 signaling

28223137

HgeneMTOR

GO:0043200

response to amino acid

18497260

HgeneMTOR

GO:0045727

positive regulation of translation

18762023

HgeneMTOR

GO:0046777

protein autophosphorylation

15467718

HgeneMTOR

GO:0071230

cellular response to amino acid stimulus

22424946

HgeneMTOR

GO:0071233

cellular response to leucine

22424946

HgeneMTOR

GO:1990253

cellular response to leucine starvation

22424946


check buttonFusion gene breakpoints across MTOR (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across GARNL3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4UCECTCGA-EY-A210-01AMTORchr1

11217209

-GARNL3chr9

130151183

+
ChimerDB4UCECTCGA-EY-A210MTORchr1

11217208

-GARNL3chr9

130151182

+
ChimerDB4UCECTCGA-EY-A210-01AMTORchr1

11217209

-GARNL3chr9

130151183

+
ChimerDB4UCECTCGA-EY-A210-01AMTORchr1

11217209

-GARNL3chr9

130151183

+


Top

Fusion Gene ORF analysis for MTOR-GARNL3

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000361445ENST00000435213MTORchr1

11217209

-GARNL3chr9

130151183

+
Frame-shiftENST00000361445ENST00000314904MTORchr1

11217209

-GARNL3chr9

130151183

+
Frame-shiftENST00000361445ENST00000373387MTORchr1

11217209

-GARNL3chr9

130151183

+
5CDS-3UTRENST00000361445ENST00000496711MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000376838ENST00000435213MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000376838ENST00000314904MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000376838ENST00000373387MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3UTRENST00000376838ENST00000496711MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000495435ENST00000435213MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000495435ENST00000314904MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3CDSENST00000495435ENST00000373387MTORchr1

11217209

-GARNL3chr9

130151183

+
intron-3UTRENST00000495435ENST00000496711MTORchr1

11217209

-GARNL3chr9

130151183

+
Frame-shiftENST00000361445ENST00000435213MTORchr1

11217208

-GARNL3chr9

130151182

+
Frame-shiftENST00000361445ENST00000314904MTORchr1

11217208

-GARNL3chr9

130151182

+
Frame-shiftENST00000361445ENST00000373387MTORchr1

11217208

-GARNL3chr9

130151182

+
5CDS-3UTRENST00000361445ENST00000496711MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000376838ENST00000435213MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000376838ENST00000314904MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000376838ENST00000373387MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3UTRENST00000376838ENST00000496711MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000495435ENST00000435213MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000495435ENST00000314904MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3CDSENST00000495435ENST00000373387MTORchr1

11217208

-GARNL3chr9

130151182

+
intron-3UTRENST00000495435ENST00000496711MTORchr1

11217208

-GARNL3chr9

130151182

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for MTOR-GARNL3


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for MTOR-GARNL3


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
MTOR

P42345

GARNL3

Q5VVW2

FUNCTION: Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals (PubMed:12087098, PubMed:12150925, PubMed:12150926, PubMed:12231510, PubMed:12718876, PubMed:14651849, PubMed:15268862, PubMed:15467718, PubMed:15545625, PubMed:15718470, PubMed:18497260, PubMed:18762023, PubMed:18925875, PubMed:20516213, PubMed:20537536, PubMed:21659604, PubMed:23429703, PubMed:23429704, PubMed:25799227, PubMed:26018084). MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2) (PubMed:15268862, PubMed:15467718, PubMed:18925875, PubMed:18497260, PubMed:20516213, PubMed:21576368, PubMed:21659604, PubMed:23429704). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis (PubMed:12087098, PubMed:12150925, PubMed:12150926, PubMed:12231510, PubMed:12718876, PubMed:14651849, PubMed:15268862, PubMed:15467718, PubMed:15545625, PubMed:15718470, PubMed:18497260, PubMed:18762023, PubMed:18925875, PubMed:20516213, PubMed:20537536, PubMed:21659604, PubMed:23429703, PubMed:23429704, PubMed:25799227, PubMed:26018084). This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E) (By similarity). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4 (PubMed:12150925, PubMed:12087098, PubMed:18925875). This also includes mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3: in the presence of nutrients, mediates phosphorylation of TFEB and TFE3, promoting their cytosolic retention and inactivation (PubMed:22576015, PubMed:22343943, PubMed:22692423). Upon starvation or lysosomal stress, inhibition of mTORC1 induces dephosphorylation and nuclear translocation of TFEB and TFE3, promoting their transcription factor activity (PubMed:22576015, PubMed:22343943, PubMed:22692423). Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex (PubMed:23429704, PubMed:23429703). Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor (PubMed:20516213). In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1 (By similarity). To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A (By similarity). mTORC1 also negatively regulates autophagy through phosphorylation of ULK1 (By similarity). Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1 (By similarity). Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP (PubMed:20537536). Also prevents autophagy by phosphorylating RUBCNL/Pacer under nutrient-rich conditions (PubMed:30704899). mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor (PubMed:21659604). Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules (PubMed:12231510). As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton (PubMed:15268862, PubMed:15467718). Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1 (PubMed:15718470). mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B (PubMed:15268862). mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422' (PubMed:18925875). Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms (By similarity). Plays an important regulatory role in the circadian clock function; regulates period length and rhythm amplitude of the suprachiasmatic nucleus (SCN) and liver clocks (By similarity). Phosphorylates SQSTM1, promoting interaction between SQSTM1 and KEAP1 and subsequent inactivation of the BCR(KEAP1) complex (By similarity). {ECO:0000250|UniProtKB:P42346, ECO:0000250|UniProtKB:Q9JLN9, ECO:0000269|PubMed:12087098, ECO:0000269|PubMed:12150925, ECO:0000269|PubMed:12150926, ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15545625, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:18762023, ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:20516213, ECO:0000269|PubMed:20537536, ECO:0000269|PubMed:21576368, ECO:0000269|PubMed:21659604, ECO:0000269|PubMed:22343943, ECO:0000269|PubMed:22576015, ECO:0000269|PubMed:22692423, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704, ECO:0000269|PubMed:25799227, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:30704899}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for MTOR-GARNL3


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for MTOR-GARNL3


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for MTOR-GARNL3


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB01590EverolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB06287TemsirolimusInhibitorSmall moleculeApproved
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00337PimecrolimusPotentiatorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB00877SirolimusInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational
HgeneMTORP42345DB12010FostamatinibInhibitorSmall moleculeApproved|Investigational

Top

Related Diseases for MTOR-GARNL3


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneMTORC1846385FOCAL CORTICAL DYSPLASIA OF TAYLOR5CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneMTORC4225259SMITH-KINGSMORE SYNDROME5GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneMTORC0041696Unipolar Depression2PSYGENET
HgeneMTORC0919267ovarian neoplasm2CTD_human
HgeneMTORC1140680Malignant neoplasm of ovary2CTD_human
HgeneMTORC1269683Major Depressive Disorder2PSYGENET
HgeneMTORC0001418Adenocarcinoma1CTD_human
HgeneMTORC0006142Malignant neoplasm of breast1CTD_human
HgeneMTORC0007102Malignant tumor of colon1CTD_human
HgeneMTORC0007131Non-Small Cell Lung Carcinoma1CTD_human
HgeneMTORC0007134Renal Cell Carcinoma1CTD_human
HgeneMTORC0007873Uterine Cervical Neoplasm1CTD_human
HgeneMTORC0009375Colonic Neoplasms1CTD_human
HgeneMTORC0014130Endocrine System Diseases1CTD_human
HgeneMTORC0017636Glioblastoma1CTD_human
HgeneMTORC0020538Hypertensive disease1CTD_human
HgeneMTORC0024232Lymphatic Metastasis1CTD_human
HgeneMTORC0025500Mesothelioma1CTD_human
HgeneMTORC0034069Pulmonary Fibrosis1CTD_human
HgeneMTORC0036341Schizophrenia1CTD_human
HgeneMTORC0149504Encephalopathy, Toxic1CTD_human
HgeneMTORC0149721Left Ventricular Hypertrophy1CTD_human
HgeneMTORC0154659Toxic Encephalitis1CTD_human
HgeneMTORC0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneMTORC0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneMTORC0205643Carcinoma, Cribriform1CTD_human
HgeneMTORC0205644Carcinoma, Granular Cell1CTD_human
HgeneMTORC0205645Adenocarcinoma, Tubular1CTD_human
HgeneMTORC0235032Neurotoxicity Syndromes1CTD_human
HgeneMTORC0262584Carcinoma, Small Cell1CTD_human
HgeneMTORC0267963Exocrine pancreatic insufficiency1CTD_human
HgeneMTORC0279702Conventional (Clear Cell) Renal Cell Carcinoma1CGI;CTD_human
HgeneMTORC0334588Giant Cell Glioblastoma1CTD_human
HgeneMTORC0334634Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse1CTD_human
HgeneMTORC0431380Cortical Dysplasia1CTD_human
HgeneMTORC0431391Hemimegalencephaly1GENOMICS_ENGLAND
HgeneMTORC0543888Epileptic encephalopathy1GENOMICS_ENGLAND
HgeneMTORC0588006Mild depression1PSYGENET
HgeneMTORC0678222Breast Carcinoma1CTD_human
HgeneMTORC0751958Lymphoma, Lymphocytic, Intermediate1CTD_human
HgeneMTORC1257931Mammary Neoplasms, Human1CTD_human
HgeneMTORC1266042Chromophobe Renal Cell Carcinoma1CTD_human
HgeneMTORC1266043Sarcomatoid Renal Cell Carcinoma1CTD_human
HgeneMTORC1266044Collecting Duct Carcinoma of the Kidney1CTD_human
HgeneMTORC1306837Papillary Renal Cell Carcinoma1CTD_human
HgeneMTORC1458155Mammary Neoplasms1CTD_human
HgeneMTORC1621958Glioblastoma Multiforme1CTD_human;UNIPROT
HgeneMTORC1955869Malformations of Cortical Development1CTD_human
HgeneMTORC1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1CTD_human
HgeneMTORC2239176Liver carcinoma1CTD_human
HgeneMTORC3714756Intellectual Disability1GENOMICS_ENGLAND
HgeneMTORC4048328cervical cancer1CTD_human
HgeneMTORC4704874Mammary Carcinoma, Human1CTD_human
HgeneMTORC4721507Alveolitis, Fibrosing1CTD_human